Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib

De la Torre-Gomar, Francisco Javier; Velasco-Amador, Juan Pablo; Prados-Carmona, Álvaro; Ruiz-Villaverde, Ricardo

doi:10.1080/09546634.2024.2304630

Journal of Dermatological Treatment

2024

DOI: 10.1080/09546634.2024.2304630

|View full text |Cite

Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib

Francisco Javier De la Torre-Gomar,

Juan Pablo Velasco-Amador,

Álvaro Prados-Carmona

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Multiple drugs

2024

Reactions Weekly

View full text Add to dashboard Cite

Multiple drugs

2024

Reactions Weekly

View full text Add to dashboard Cite

Alopecia areata treatment with baricitinib: different relapse phenotypes

Dall’Oglio,

Nasca,

Lacarrubba

et al. 2024

Journal of Dermatological Treatment

View full text Add to dashboard Cite

Drug-Induced Alopecia Areata From Upadacitinib

Chang,

Brownstone,

Hsu

2024

Cureus

View full text Add to dashboard Cite

This case report describes an unexpected occurrence of alopecia areata (AA) in a 55-year-old woman undergoing treatment with upadacitinib for atopic dermatitis. This patient developed AA approximately one year into her upadacitinib treatment for atopic dermatitis. This case highlights possible upadacitinib-induced AA, which has not been reported in the literature. Not only does this case demonstrate the typical timeline for drug-induced alopecia, but it also raises questions about whether upadacitinib can cause drug-induced alopecia.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib

Cited by 3 publications

References 9 publications

Multiple drugs

Multiple drugs

Alopecia areata treatment with baricitinib: different relapse phenotypes

Drug-Induced Alopecia Areata From Upadacitinib

Contact Info

Product

Resources

About